ACL recovery pill trial pulled before it began

NCT ID NCT07115056

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to test whether taking tranexamic acid pills for 10 days after ACL knee surgery could reduce pain and improve recovery in 100 teens and young adults. However, the trial was withdrawn before enrolling anyone, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tranexamic acid (TXA)
What this could lead to
If it had worked, this could have pointed toward a simple, cheap way to reduce pain and speed up recovery after ACL surgery.
What could go wrong
The trial was withdrawn before it started, so we have no results. Even if it had run, it was a small, early-phase study that might not have shown clear benefits or been generalizable to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Campbell Clinic

    Germantown, Tennessee, 38138, United States

  • Duke University School of Medicine

    Durham, North Carolina, 27705, United States

  • Endeavor Health

    Evanston, Illinois, 60201, United States

  • University of Cincinnati

    Cincinnati, Ohio, 45221, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

  • Washington University School of Medicine in St. Louis

    Chesterfield, Missouri, 63017, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.